Skip to navigation Skip to content

Giant cell arteritis (GCA) Program in Pharmaceutical Benefits Scheme (PBS) 012-19072601

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised tocilizumab for patients with active Giant cell arteritis (GCA).

GCA and listing dates

GCA is an inflammation of blood vessels in and around the scalp.

Listing date: tocilizumab - 1 August 2019

Note: patients must be aged 50 years or older.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex Drugs Program team and choose the option relevant to the condition treated.

The Resources page contains:

  • restriction and item codes
  • contact details
  • application forms
  • Services Australia website link
  • FAQs from Service Officers

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Written Authority Required Drugs